Design Therapeutics bobbled around today only ended up 0.27% since yesterday.
The company isn't at an immediate support or resistance level that might be predictive. Design Therapeutics hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. DSGN might find some support at the 2.33 level, buyers might push the price back up from here. But it's not very clear what will happen.